Why Dynavax Stock Was Winning This Week
Dynavax Technologies (NASDAQ: DVAX), a biotech company that has been a popular stock throughout the coronavirus pandemic, was doing very well this week. According to data compiled by S&P Global Market Intelligence, Dynavax's shares were up by 16% week to date as of Thursday night, on the back of a worrying rise in COVID-19 cases and fatalities in several parts of the world.
A resurgent coronavirus anywhere in the world means more vaccination pushes, which benefits the business of Dynavax. The company has done well through the pandemic because of its CpG 1018 adjuvant, which is used in several COVID vaccines either on the market or in development.
Image source: Getty Images.
Source Fool.com
